Kiora Pharmaceuticals press release (NASDAQ:KPRX): FY net loss was $12.5 million for 2023 compared to $13.6 million for 2022. Kiora ended the year with $2.5 million in cash and cash equivalents and $...
Source LinkKiora Pharmaceuticals press release (NASDAQ:KPRX): FY net loss was $12.5 million for 2023 compared to $13.6 million for 2022. Kiora ended the year with $2.5 million in cash and cash equivalents and $...
Source Link
Comments